Inspire Medical Systems Inc (INSP)
214.93
+9.93
(+4.84%)
USD |
NYSE |
Oct 04, 16:00
214.45
-0.48
(-0.22%)
After-Hours: 20:00
Inspire Medical Systems SG&A Expense (TTM): 495.06M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 495.06M |
March 31, 2024 | 475.59M |
December 31, 2023 | 451.96M |
September 30, 2023 | 422.69M |
June 30, 2023 | 395.04M |
March 31, 2023 | 359.11M |
December 31, 2022 | 320.69M |
September 30, 2022 | 284.62M |
June 30, 2022 | 252.26M |
March 31, 2022 | 224.27M |
December 31, 2021 | 202.62M |
September 30, 2021 | 182.47M |
June 30, 2021 | 162.44M |
March 31, 2021 | 140.73M |
Date | Value |
---|---|
December 31, 2020 | 127.87M |
September 30, 2020 | 117.44M |
June 30, 2020 | 106.66M |
March 31, 2020 | 99.95M |
December 31, 2019 | 90.46M |
September 30, 2019 | 78.38M |
June 30, 2019 | 69.41M |
March 31, 2019 | 61.88M |
December 31, 2018 | 53.53M |
September 30, 2018 | 47.66M |
June 30, 2018 | 42.37M |
March 31, 2018 | 36.94M |
December 31, 2017 | 32.36M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
90.46M
Minimum
Dec 2019
495.06M
Maximum
Jun 2024
258.52M
Average
224.27M
Median
Mar 2022
SG&A Expense (TTM) Benchmarks
Nevro Corp | 326.85M |
Axonics Inc | 264.58M |
Inari Medical Inc | 406.98M |
Electromed Inc | 34.49M |
Myomo Inc | 20.12M |